Merck Sharp & Dohme LlcUsage: KEYTRUDA is indicated for various cancers, including unresectable or metastatic melanoma, non-small cell lung cancer (NSCLC), malignant pleural mesothelioma, head and neck squamous cell carcinoma, classical Hodgkin lymphoma, and several others. It targets PD-1 to boost immune response against tumors.